Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment

Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment

Joshua M. Bauml, MD, assistant professor, University of Pennsylvania, discusses a novel IT platform designed to enhance lung cancer clinical trial enrollment. More at http://onclive.com/